Literature DB >> 32461228

Protecting children in low-income and middle-income countries from COVID-19.

Salahuddin Ahmed1,2, Tisungane Mvalo3,4, Samuel Akech5, Ambrose Agweyu5, Kevin Baker6, Naor Bar-Zeev7, Harry Campbell2,8, William Checkley9, Mohammod Jobayer Chisti10, Tim Colbourn11, Steve Cunningham2,12, Trevor Duke13,14,15, Mike English5,16, Adegoke G Falade17, Nicholas Ss Fancourt18, Amy S Ginsburg19, Hamish R Graham20,21, Diane M Gray22, Madhu Gupta23, Laura Hammitt7, Anneke C Hesseling24, Shubhada Hooli25, Abdul-Wahab Br Johnson26, Carina King27, Miles A Kirby28,29, Claudio F Lanata30,31, Norman Lufesi32, Grant A Mackenzie33,34,35, John P McCracken36, Peter P Moschovis37, Harish Nair2,8, Osawaru Oviawe38, William S Pomat39, Mathuram Santosham7, James A Seddon24,40, Lineo Keneuoe Thahane41,42,43, Brian Wahl7, Marieke Van der Zalm44, Charl Verwey45,46, Lay-Myint Yoshida47, Heather J Zar48,49, Stephen Rc Howie50, Eric D McCollum51,52.   

Abstract

Entities:  

Keywords:  child health; paediatrics; pneumonia; respiratory infections

Mesh:

Year:  2020        PMID: 32461228      PMCID: PMC7254117          DOI: 10.1136/bmjgh-2020-002844

Source DB:  PubMed          Journal:  BMJ Glob Health        ISSN: 2059-7908


× No keyword cloud information.
A saving grace of the COVID-19 pandemic in high-income and upper middle-income countries has been the relative sparing of children. As the disease spreads across low-income and middle-income countries (LMICs), long-standing system vulnerabilities may tragically manifest, and we worry that children will be increasingly impacted, both directly and indirectly. Drawing on our shared child pneumonia experience globally, we highlight these potential impacts on children in LMICs and propose actions for a collective response. Current data suggest children are susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection but are less likely than adults to become severely ill.1–4 Although at first glance these data appear reassuring, the child pneumonia, and broader global child health, experience provides a forewarning of what may be coming in LMICs. High-income countries (HICs) have an under-5 pneumonia mortality rate of 3 per 100 000.5 In contrast, the rate in LMICs is 200 per 100 000 population, with pneumonia the leading infectious cause of under-5 death globally.5 While yet unknown, COVID-19, a viral pneumonia syndrome, may impact children in LMICs more severely than what has been observed to date. The risk factors for poor outcomes in pneumonia are overwhelmingly more prevalent in LMICs than HICs. These include severe malnutrition, low immunisation uptake, nutritional anaemia, HIV exposure or infection, air pollution, poverty, low parental education and, crucially, limited access to high-quality acute healthcare.6 7 In HICs, vulnerable children are being actively ‘shielded’ from infection, but in LMICs, most will remain exposed. The indirect effects of the COVID-19 response need attention as they are an enormous threat to the well-being of children. These include widespread parental unemployment, disrupted education, food and housing insecurity and threats to vital preventive health programmes, like immunisation, antenatal care, infant feeding and mental health. The acute care workforce may soon be overwhelmed by COVID-19 needs, and we anticipate critical healthcare services being diverted away from mothers and children. Delays in care seeking may worsen, resulting in more severe illness. So, while transmission of respiratory pathogens may be slowed by pandemic response measures, these measures could accentuate well-established risk factors for poor paediatric outcomes and undermine healthcare systems’ abilities to respond. What can be done to protect children in LMICs? First, we must prevent the collapse of vital acute care (oxygen, antibiotics, personal protective equipment (PPE)), preventive services (immunisation, maternity care, breastfeeding and nutrition programmes, HIV and malaria prevention) and supply chains and take opportunities for system strengthening that could be a legacy of the pandemic. Maintaining a critical workforce in maternal and child health, enabling healthcare workers to use PPE and empowering community health workers to engage with communities in the response are essential. These measures, taken locally with decisive international support, are likely to save more children’s lives than advanced intensive care and should benefit children with COVID-19 and other illnesses, including pneumonia. Second, COVID-19 testing in LMICs needs massive upscaling and outreach. If we are to understand paediatric COVID-19, surveillance systems—both pandemic and pneumonia focused—need investment for rapid scale-up and testing of children with respiratory illnesses for SARS-CoV-2, testing paediatric contacts of adult cases and accurately reporting child deaths. Third, pandemic lockdown strategies should maintain vital access to care and be tailored to the particular social, economic and health environments of LMICs. This may not mean following the approach of HICs. Rather, LMICs should also build on their experience and expertise gained during other epidemics and make decisions based on their reality, workforce capacity, population density and migration patterns. Examples could be establishing separate areas in clinics for preventative care by dedicated non-respiratory staff, home vaccination visits, outposts responsible for delivery of household essentials to COVID-19 affected households, retraining newly unemployed people to assist with case finding and contact tracing and sewing groups to produce face masks to support widespread mask strategies. Fourth, research is key to better understanding COVID-19 fundamentals on children, younger and older, including their role in transmission dynamics, spectrum of illness and outcomes, the impact of comorbidities and common coinfections (viral, bacterial, mycobacterial and parasitic) and how broader pandemic responses impact on health behaviours and outcomes. To accomplish this requires COVID-19 surveillance and rapid cycle research on the effects of pandemic response strategies and context-informed modelling using the best available data and locally relevant assumptions. Understanding COVID-19 in children is essential to developing informed, nuanced pandemic responses, including eventual vaccination strategies. These efforts must be country-driven, network-building, joint global initiatives supported by the international community for the benefit of all. We expect children in LMICs may be seriously impacted by COVID-19, potentially both directly and indirectly. Balanced strategies that protect children must be central to coordinated and cooperative global pandemic response efforts.
  7 in total

1.  Epidemiology of COVID-19 Among Children in China.

Authors:  Yuanyuan Dong; Xi Mo; Yabin Hu; Xin Qi; Fan Jiang; Zhongyi Jiang; Shilu Tong
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

Review 2.  Risk factors for mortality from acute lower respiratory infections (ALRI) in children under five years of age in low and middle-income countries: a systematic review and meta-analysis of observational studies.

Authors:  Michela Sonego; Maria Chiara Pellegrin; Genevieve Becker; Marzia Lazzerini
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

Review 3.  Hypoxaemia as a Mortality Risk Factor in Acute Lower Respiratory Infections in Children in Low and Middle-Income Countries: Systematic Review and Meta-Analysis.

Authors:  Marzia Lazzerini; Michela Sonego; Maria Chiara Pellegrin
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

4.  Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-10       Impact factor: 17.586

5.  Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain.

Authors:  Alfredo Tagarro; Cristina Epalza; Mar Santos; Francisco José Sanz-Santaeufemia; Enrique Otheo; Cinta Moraleda; Cristina Calvo
Journal:  JAMA Pediatr       Date:  2020-04-08       Impact factor: 16.193

6.  SARS-CoV-2 Infection in Children.

Authors:  Xiaoxia Lu; Liqiong Zhang; Hui Du; Jingjing Zhang; Yuan Y Li; Jingyu Qu; Wenxin Zhang; Youjie Wang; Shuangshuang Bao; Ying Li; Chuansha Wu; Hongxiu Liu; Di Liu; Jianbo Shao; Xuehua Peng; Yonghong Yang; Zhisheng Liu; Yun Xiang; Furong Zhang; Rona M Silva; Kent E Pinkerton; Kunling Shen; Han Xiao; Shunqing Xu; Gary W K Wong
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

7.  Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Infect Dis       Date:  2019-10-31       Impact factor: 25.071

  7 in total
  11 in total

1.  Indirect impacts of the COVID-19 pandemic at two tertiary neonatal units in Zimbabwe and Malawi: an interrupted time series analysis.

Authors:  Simbarashe Chimhuya; Samuel R Neal; Gwen Chimhini; Hannah Gannon; Mario Cortina Borja; Caroline Crehan; Deliwe Nkhoma; Tarisai Chiyaka; Emma Wilson; Tim Hull-Bailey; Felicity Fitzgerald; Msandeni Chiume; Michelle Heys
Journal:  BMJ Open       Date:  2022-06-21       Impact factor: 3.006

Review 2.  COVID-19 and Pediatric Lung Disease: A South African Tertiary Center Experience.

Authors:  Diane M Gray; Mary-Ann Davies; Leah Githinji; Michael Levin; Muntanga Mapani; Zandiswa Nowalaza; Norbertta Washaya; Aamir Yassin; Marco Zampoli; Heather J Zar; Aneesa Vanker
Journal:  Front Pediatr       Date:  2021-01-20       Impact factor: 3.418

Review 3.  COVID-19 Rehab Fright Management.

Authors:  Nazia Mumtaz; Ghulam Saqulain; Nadir Mumtaz
Journal:  Pak J Med Sci       Date:  2021 Jan-Feb       Impact factor: 1.088

Review 4.  Parents' and Guardians' Willingness to Vaccinate Their Children against COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Feifan Chen; Yalin He; Yuan Shi
Journal:  Vaccines (Basel)       Date:  2022-01-24

Review 5.  Things must not fall apart: the ripple effects of the COVID-19 pandemic on children in sub-Saharan Africa.

Authors:  Modupe Coker; Morenike O Folayan; Ian C Michelow; Regina E Oladokun; Nguavese Torbunde; Nadia A Sam-Agudu
Journal:  Pediatr Res       Date:  2020-09-24       Impact factor: 3.756

6.  COVID-19 apocalypse for children: Predictable, preventable?

Authors:  Henry A Kilham
Journal:  J Paediatr Child Health       Date:  2020-08       Impact factor: 1.954

7.  Caregiver acceptance of an anticipated COVID-19 vaccination.

Authors:  Ronnie R Marquez; Elizabeth S Gosnell; S Thikkurissy; Scott B Schwartz; Jennifer L Cully
Journal:  J Am Dent Assoc       Date:  2021-03-24       Impact factor: 3.634

8.  Where to make a difference: research and the social determinants in pediatrics and child health in the COVID-19 era.

Authors:  Peter Lachman
Journal:  Pediatr Res       Date:  2020-11-10       Impact factor: 3.756

Review 9.  Considerations for diagnostic COVID-19 tests.

Authors:  Olivier Vandenberg; Delphine Martiny; Olivier Rochas; Alex van Belkum; Zisis Kozlakidis
Journal:  Nat Rev Microbiol       Date:  2020-10-14       Impact factor: 78.297

10.  Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2-Related Illness in Children: Hospital Experience in Cape Town, South Africa.

Authors:  Marieke M van der Zalm; Juanita Lishman; Lilly M Verhagen; Andrew Redfern; Liezl Smit; Mikhail Barday; Dries Ruttens; A'ishah da Costa; Sandra van Jaarsveld; Justina Itana; Neshaad Schrueder; Marije Van Schalkwyk; Noor Parker; Ilse Appel; Barend Fourie; Mathilda Claassen; Jessica J Workman; Pierre Goussard; Gert Van Zyl; Helena Rabie
Journal:  Clin Infect Dis       Date:  2021-06-15       Impact factor: 20.999

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.